ELVN - Financial Reports List - Enliven Therapeutics, Inc. - IntrinsicAlpha

Enliven Therapeutics, Inc. ELVN

Healthcare - Biotechnology - NASDAQ - US

$ 17.4

-1.88 %

$ 853 M

Market Cap

-8.58

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-19.67%	-18.33%
Annual Report	FY	10-K	2024-12-31	0.00%	-24.36%	-25.17%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-11.49%	-11.63%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-19.31%	-22.20%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-74.50%	-58.28%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-60.18%	-597.85%
Annual Report	FY	10-K	2023-12-31	0.00%	-89.63%	-115.33%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-96.79%	-121.77%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-88.11%	-123.31%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-50.31%	-89.19%

1